Introduction
Heart failure is the end stage for all heart diseases. Because of longevity of life and modern diagnostic equipments and advanced management, disease burden due to heart failure keeps on increasing. In developing countries like India, infectious disease like Rheumatic valvular heart disease still contributing much of this disease burden. Because of the westernisation trend noninfectious causes like metabolic disease started increasing in the last decade¹. For a proper and methodical algorithmic approach in the management of heart failure, we need a simple but effective prognostic model. This model should contain all the variables which are easily available, cheaper and prognostically significant. They have to predict the outcome in an easily explained way, so that we can discuss with the patients and relatives about the prognosis and the need for further advanced interventions. Over a period of decade, various attempts have been made for this simple but effective model, which includes variables like BNP, NT-pro BNP, C Reactive protein, high sensitivity CRP, Interleukin-6, ESR, and echocardiographic parameters². But, nothing fits into the category of 'ideal'. Variables like BNP has helped much in the diagnosis and prognosis determination of heart failure cases 8 . However, their added benefits in guiding therapy remain unknown .Other caveat in using these variables is, these markers are not unique for heart failure alone and these can also be elevated in other clinical conditions. Therefore, natriuretic peptides are not always sufficient.
Recently, elevated red cell distribution width (RDW) has been identified and proposed as a statistically significant prognostic marker in heart failure⁴. Red cell distribution width is a measure of the variability in size of circulating red blood cells and is expressed as the coefficient of variation or in standard deviation format. As many of the basic hematology autoanalysers can produce RDW as one of many parameters, this can be used in the prognostic model of heart failure. As RDW is a hematological parameter routinely obtained as a part of CBC, the association between RDW and mortality might provide a valid reason to introduce this easy and inexpensive RDW in algorithms for cardiovascular risk prediction and management strategies. Thus explore the possibility of RDW to www.jmscr.igmpublication.org Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i2.201 serve as a reference indicator for clinicians to provide relevant information in stratifying high risk patients.
Aims and Objectives
 To study the correlation between RDW and NYHA classification of heart failure  To analyse the relationship between RDW and the severity of heart failure  To analyse the relationship between RDW and the prognosis of Cardiac failure.
Methodology
This case control study was conducted in Mahathma Gandhi memorial Government hospital, Trichy and was carried out from August 2016 to July 2017. All patients admitted in the medical ward were taken up for the study.
Operational definition-Case: Heart failure patients due to various etiologies who meet the following inclusion criteria and not presenting the following exclusion criteria will be selected. Controls were selected as per the selection criteria and they were also subjected to the same modalities of examination and investigations.
Statistical Methods
One-way analysis of variance (ANOVA) intergroup comparison was used to examine the association between RDW and heart failure. Data was analysed using simple descriptive statistics. Two-sided tests were used and a P-value of less than 0.05 was considered as statistically significant in all the considered variables.
Results
In this case control study 182 cases and 50 controls were taken up for the study. Among the cases, males 120(65.9%) and females 62(34.1%) and among the controls, males 33(66%) and 17(33%) were females. Majority of cases had coronary heart disease 124(68%) followed by valvular heart disease 23 ( 
Mean RDW
In 50 controls enrolled in the study , mean RDW was 37.78 and this value is significantly lower compared to all cases or comparing with NYHA I stage as per statistical analysis with the 'p'value of <o.oo1. In the male controls mean RDW value was 37.23 and when this value is compared with the mean RDW among cases i.e. 46.65 it showed positive prediction of significant heart failure with the RDW cut off above 45. Even comparing the control value with the individual NYHA groups in failure cases, that also showed 'p' value of <0.001 and this was very much significant statistically. Among 17 female controls enrolled in our study the mean RDW was 38.85 and when compared this value with female group's value of 49.00 , 'p' value was < 0.001 when analysed on chi square test. While splitting the female groups as per NYHA staging also shows the mean RDW values progresses dynamically from control group to progressive NYHA groups. This RDW values correlate very well with NYHA staging.
In the NYHA staging as mentioned before, the LVEF diminishes progressively from NYHA I to IV. Like that RDW-CV values also raises dynamically in parallel to the worsening heart failure stages. (47.3 ± 6.8) . But there were no significant difference compared to non smokers group (47.6±7.5 p: 0.08).By using pearson correlation test , higher number of cases with high RDW were smokers ( 65% smokers p < 0.05 ). So, smoking as a confounding factor is ruled out. Our study correlates well with the study done by parlak et al in Turkey in 2012.
RDW-cv between Cases and Controls:
B) Blood Pressure 68% of heart failure patients are hypertensive. This value is highly significant risk factor for heart failure development 'p' value <0.005 Hemoglobin Average Hemoglobin among the 'cases' were 12.71 g%, in 'control' group 12.77 g%. Even though anemia is considered as a precipitating and risk factor for heart failure, because of selection bias there is no significant reduction in haemoglobin levels in patients. So, anemia as a confounding factor is ruled out for the elevation of RDW in heart failure patients.
RDW:
The mean RDW among case were 47.58 and among control group 37.78 Among the NYHA classification in the heart failure group the mean RDW value for NYHA II is 43.52 , For NYHA III 46.9 and For NYHA IV 53.20 . The value among these control and case groups and among the NYHA groups is statistically significant ( p value < 0.0001). RDW rise in heart failure shows linear correlation with the progression of heart failure. Among the males, control group have the mean RDW of 37.23 and case group have 46.65 and this value is statistically significant. Among females, control group have the mean RDW of 38.85 and case group have 49.00. The slight rise in the RDW values in females in both the group correlates with the higher levels of estrogen. Normal value of RDW-CV for Male ranges from 35.1-43.9 and For females 36.4-46.3 and our study confirms this higher value in females.
Mechanism of RDW Rise in Heart Failure
RDW is used to evaluate variance in the size and form of red cells. RDW is a coefficient of variation of MCV, therefore higher RDW values reflect greater heterogeneity in MCV (anisocytosis). This heterogenicity in MCV is usually caused by variation in the maturation and degradation rate among the erythrocyte group. Recent researches clearly pointed out the prognostic importance of RDW rise among heart failure patients and regarded as a prognostic marker. But the mechanisms underlying the association between RDW and severity of LV dysfunction and its role in predicting mortality in heart failure remains elusive to all the researchers in all these years. Although exact physiologic mechanism is unknown, systemic factors that alter erythrocyte homeostasis such as inflammation and oxidative stress has been proposed as the potential mechanisms behind this rise of RDW among heart failure cases.
Inflammatory Theory⁵
Role of inflammatory mediators in the pathogenesis of heart failure have been proved beyond doubt. Recent study has shown positive correlation between RDW and the inflammatory markers among the heart failure patients, which was independant of other confounding variables like old age, sex, ferritin or other blood indices. This inflammatory mechanism affects the RDW by three mechanisms. 1) Inflammatory mediators inhibiting the erythrocyte production and diminishes the responsiveness of bone marrow to erythropoietin. 2) All the inflammatory mediators which are in elevated levels in heart failure , shorten the survival period of erythrocytes. 3) Inflammatory mediators impairs iron metabolism. Oxidative Stress Theory Heart failure is associated with higher oxidative stress. Oxidative stress causes increase in anisocytosis by disrupting erythropoiesis and to alter blood cell membrane abnormality and red blood cell circulation half life, ultimately leading to increased RDW⁶.
Limitations of this Study
As this study was performed in a cross section format, we did not observe the RDW values dynamically over a period of time. So, it is very hard to get the nature of elevation in RDW values among the heart failure patients whether the values progressed in a same stepwise manner like left ventricle dysfunction or not. We did not investigate further about the causes of elevated RDW values like serum ferritin , serum iron estimation, TIBC or serum folate and cobalamin estimation. These may play as a confounding factor in RDW estimation. Because RDW values are easily attainable by means of routine CBC investigation, and it is highly reproducible in a given patient, it may serve as an important biomarker in determining the prognosis of heart failure.
